WuXi AppTec's net profit doubled in the first half of the year, increasing by 101.92%. The company raised its full-year sales forecast | Financial Report Insights

WuXi AppTec's performance in the first half of 2025 was impressive, with operating revenue of 20.8 billion yuan, a year-on-year increase of 20.64%, and net profit attributable to shareholders soaring by 101.92% year-on-year. The company expects its continuing operations revenue to return to double-digit growth in 2025, with the growth rate adjusted from 10-15% to 13-17%. The overall revenue for the year is expected to be adjusted from 41.5-43 billion yuan to 42.5-43.5 billion yuan. On the 28th, WuXi AppTec's semi-annual financial report: Revenue in the first half of 2025 was 20.8 billion yuan, a year-on-year increase of 20.64%; Net profit attributable to shareholders was 8.56 billion yuan, a year-on-year surge of 101.92%; Net profit excluding non-recurring items was 5.58 billion yuan, an increase of 26.47%. Basic earnings per share were 3.01 yuan, a year-on-year increase of 106.16%. Net cash flow from operating activities was 7.43 billion yuan, a year-on-year increase of 49.63%. Revenue Growth Momentum Remains Strong, Profit Margins Significantly Improve Operating revenue was 20.8 billion yuan, a year-on-year increase of 20.64%. As a global leading CRO service provider, WuXi AppTec's revenue growth directly reflects the prosperity of the global new drug research and development market. Most notably, net profit attributable to shareholders reached 8.56 billion yuan, a staggering year-on-year increase of 101.92%, which far exceeds the revenue growth, indicating a significant improvement in the company's profitability. Net profit excluding non-recurring items was 5.58 billion yuan, a year-on-year increase of 26.47%. Although the growth rate is relatively lower, it still maintains a good growth trend. The weighted average return on net assets reached 13.93%, a substantial increase of 6.31 percentage points compared to the same period last year. This improvement in the indicator indicates that the company's capital utilization efficiency is continuously optimizing. Basic earnings per share were 3.01 yuan, a year-on-year increase of 106.16%, providing substantial returns to shareholders. Cash Flow Performance Exceeds Expectations, Generous Dividends Reflect Management Confidence Net cash flow from operating activities was 7.43 billion yuan, a year-on-year increase of 49.63%. Total assets were 83.82 billion yuan, an increase of 4.35% compared to the beginning of the year; net assets attributable to shareholders were 59.91 billion yuan, an increase of 2.18% compared to the beginning of the year. Meanwhile, the company has demonstrated a rather generous dividend policy: a special dividend of 3.5 yuan per 10 shares has been implemented, with an additional 3.5 yuan to be distributed in the interim, totaling 7 yuan per 10 shares. The special dividend has already distributed cash dividends of approximately 1.01 billion yuan, and the interim dividend is expected to distribute about 1 billion yuan, bringing the total dividend amount to over 2 billion yuan. From the perspective of shareholder structure, the top ten shareholders, including G&C series companies and related concerted actors, collectively hold over 14% of the shares, indicating a relatively concentrated equity. Hong Kong Central Clearing Limited, as the nominal holder under the Shanghai-Hong Kong Stock Connect, holds 10.50% of the shares, reflecting continued foreign interest in the company